BioAge Labs, Inc. Common Stock, par value $0.00001 per share Underwriting AgreementUnderwriting Agreement • September 18th, 2024 • BioAge Labs, Inc. • Pharmaceutical preparations
FORM OF INDEMNITY AGREEMENTIndemnification & Liability • September 18th, 2024 • BioAge Labs, Inc. • Pharmaceutical preparations • Delaware
This Indemnity Agreement, dated as of _____________, 2024 is made by and between BioAge Labs, Inc., a Delaware corporation (the “Company”), and _____________________, a director, officer or key employee of the Company or one of the Company’s Subsidiaries or Affiliates (as those terms are defined below) or other service provider who satisfies the definition of Indemnifiable Person set forth below (“Indemnitee”).
